New ALS medication now available to Albertans

Radicava, the second medication approved to treat amyotrophic lateral sclerosis or ALS, is now available to Albertans with government-sponsored drug coverage.

For the past 20 years, individuals with ALS have only had one approved drug treatment option.

“With only one medication available for this progressive neurodegenerative disease, providing Albertans with another treatment option is vital. June is ALS Awareness Month and providing access to this new drug is the best way to demonstrate our support for those living with ALS.” Tyler Shandro, Minister of Health

ALS is an illness involving progressive paralysis of an individual’s voluntary muscles. Its cause is unknown. Symptoms of ALS often include loss of motor control, muscle weakness, fatigue, stiffness, muscle cramping and twitching.

Drug treatment may help to slow a patient’s loss of function and mobility, enabling them to better manage the disease and improve their quality of life.

“We applaud the Alberta government for providing Albertans with access to Radicava through government-sponsored drug coverage. The availability of new drug therapies is critical for people living with this terminal disease and gives hope for new treatments. This is a significant milestone for Albertans affected by ALS.” Karen Caughey, Executive Director, ALS Society of Alberta

ALS Society of Alberta

Provincial Press Release June 18, 2020 @ 1:32 PM

  • Facebook
  • Instagram stettler
  • Twitter
  • TV

Stettler News


Stettler News

Local Sports

Alberta News

Canada News

Global News


2020 Graduates


Clearview Public School District


Job Board



Public Notices


Workshop & Classes



Get Stettler news today for sports, events, entertainment, jobs, and obituaries, relevant to residents of Stettler, AB, Canada on

Your locally owned news source for Town of Stettler and County of Stettler, AB Canada

© 2020 Rairdan Services, Inc.  |  Stettler, AB  |  | Jewel Theatre | Photos not to be used without permission